References
- Reynolds , J. E.F. 1989 . Martindale. The Extrapharmacopaeia , 29th Ed. 828 London : Pharmaceuticals Press .
- Hardman , J. G. , Gilman , A. G. and Limbird , L. E. 2001 . “ Goodman & Gilman ” . In The Pharmacological Basis of Therapeutics Edited by: Hardman , J. G. , Gilman , A. G. and Limbird , L. E. New York , NY : McGraw‐Hill Co. .
- Cuena Boy , R. , Ortiz de Apodaca Ruiz , M. A. and Macia Martinez , M. A. 2002 . Best result of digoxin dosing in the aged by taking into account that both the elimination as well as the volume of distribution of the drug decrease when the kidney function deteriorates . Anales de Medicina Interna , 19 : 331 – 335 . [PUBMED] [INFOTRIEVE] [CSA]
- Aronson , J. K. 1980 . Clinical pharmacokinetics of digoxin . Clin. Pharmacokin. , 5 : 137 – 149 .
- Moffat , A. C. , Jackson , J. V. , Moss , M. S. and Widdop , B. 1986 . Clarke's Isolation and Identification of Drugs in Pharmaceuticals Body Fluids and Post Mortem Materials , 2nd Ed. 425 London : Pharmaceutical Press .
- 1995 . Rockville , MD : U.S. Pharmacopial Conversion . The United States of Pharmacopoeia 23/National Formulary 18
- 1994 . Vol. 8, No. 2 , WHO: Drug Information
- 1992 . WHO: Helsinki Declaration Vol. 6, No. 4 , WHO: Drug Information
- Hauschke , D. , Steinijans , V. W. and Dilenl , E. 1990 . A distribution‐free procedure for the statistical analysis of bioequivalence studies . Int. J. Clin. Pharmacol. Therap. Toxicol. , 28 : 72 – 78 .
- Schulz , H. U. and Steinijans , V. W. 1992 . Striving for standards in bioequivalence assessment . A review. Int. J. Clin. Pharmacol. Therapy & Toxicol. , 30 ( Suppl. 1 ) : S1 – S6 .
- Henderson , J. D. and Esham , R. H. 2001 . Generic issues for problematic drugs . Southern Med. J. , 94 : 16 – 21 . [CSA]